Stock ADK DIAGNOS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases DIAGNOS Inc.

Equities

ADK

CA2524423068

Delayed Toronto S.E.
Other stock markets
 18:09:51 10/05/2024 BST 		5-day change 1st Jan Change
0.305 CAD +1.67% Intraday chart for DIAGNOS Inc. -4.69% -24.69%
05-06 Diagnos Inc. Announces to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024 CI
04-16 DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DIAGNOS Announces Closing of First Tranche of Private Placement
AQ
DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
AQ
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
AQ
DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
AQ
DIAGNOS Announces Grant of Stock Options
AQ
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors
AQ
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
AQ
DIAGNOS Announces Grant of Stock Options
AQ
DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors
AQ
DIAGNOS Announces Closing of First Tranche of Private Placement
AQ
Diagnos Announces Variation in One Insider Ownership of Common Shares
AQ
DIAGNOS recognized as a Top TSX Venture Exchange Company
AQ
DIAGNOS Appoints New Chief Operating Officer
AQ
DIAGNOS Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica, a Global Leader in Vision Care
AQ
Canadian Investment Regulatory Organization Trade Resumption - ADK
AQ
Canadian Investment Regulatory Organization Trading Halt - ADK
AQ
DIAGNOS Announces Closing of Private Placement
AQ
DIAGNOS : États financiers T2-2024 – Télécharger le
PU
DIAGNOS : Rapport de gestion T2-2024 – Télécharger le
PU
DIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & Endocrinology
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADK Stock
  4. News DIAGNOS Inc.
  5. Press Releases